Bipolar • LB Pharmaceuticals

LB-102-011

For adults with a diagnosis of Bipolar I Disorder currently experiencing a Major Depressive Episode (MDE).

The goal of this study is to evaluate the efficacy, safety, and tolerability of LB-102, compared to placebo, in treating depressive symptoms associated with Bipolar I Disorder.

This study is sponsored by LB Pharmaceuticals.